Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Delia Johnson

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
American Journal of Preventive Medicine|May 30, 2007
Discontinuing hormone replacement therapy: attenuating the effect on CVD risk with lifestyle changesKelley K Pettee, Andrea M Kriska, Molly B Conroy, et al.
Circulation|February 19, 2004
Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) studyKevin E Kip, Oscar C Marroquin, David E Kelley, et al.
Plos One|May 8, 2015
Renal function and coronary microvascular dysfunction in women with symptoms/signs of ischemiaRajesh Mohandas, Mark S Segal, Tianyao Huo, et al.
American Heart Journal Plus : Cardiology Research and Practice|June 14, 2024
Endogenous androgens, coronary atheroma and remodeling in women with suspected ischemic heart disease: A report from the Women's Ischemia Syndrome Evaluation (WISE) studySachini Ranasinghe, Ankur Jain, Yasmeen Taha, et al.
Cardiovascular Diagnosis and Therapy|September 15, 2018
Extent of coronary atherosclerosis and arterial remodelling in women: the NHLBI-sponsored Women's Ischemia Syndrome EvaluationStephen J Nicholls, E Murat Tuzcu, Kathy Wolski, et al.
Journal of the American College of Cardiology|June 29, 2010
Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) studyCarl J Pepine, R David Anderson, Barry L Sharaf, et al.
Journal of the American Heart Association|March 4, 2014
Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE StudySteven M Smith, Tianyao Huo, B Delia Johnson, et al.
Journal of Women'S Health (2002)|November 8, 2006
Lifestyle intervention and coronary heart disease risk factor changes over 18 months in postmenopausal women: the Women On the Move through Activity and Nutrition (WOMAN study) clinical trialLewis H Kuller, Laura S Kinzel, Kelley K Pettee, et al.
Journal of the American College of Cardiology|November 21, 2007
Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE studyViola Vaccarino, B Delia Johnson, David S Sheps, et al.
American Heart Journal|March 3, 2015
Mild renal dysfunction and long-term adverse outcomes in women with chest pain: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)Rajesh Mohandas, Mark Segal, Titte R Srinivas, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
American Journal of Preventive Medicine|May 30, 2007
Discontinuing hormone replacement therapy: attenuating the effect on CVD risk with lifestyle changesKelley K Pettee, Andrea M Kriska, Molly B Conroy, et al.
Circulation|February 19, 2004
Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) studyKevin E Kip, Oscar C Marroquin, David E Kelley, et al.
Plos One|May 8, 2015
Renal function and coronary microvascular dysfunction in women with symptoms/signs of ischemiaRajesh Mohandas, Mark S Segal, Tianyao Huo, et al.
American Heart Journal Plus : Cardiology Research and Practice|June 14, 2024
Endogenous androgens, coronary atheroma and remodeling in women with suspected ischemic heart disease: A report from the Women's Ischemia Syndrome Evaluation (WISE) studySachini Ranasinghe, Ankur Jain, Yasmeen Taha, et al.
Cardiovascular Diagnosis and Therapy|September 15, 2018
Extent of coronary atherosclerosis and arterial remodelling in women: the NHLBI-sponsored Women's Ischemia Syndrome EvaluationStephen J Nicholls, E Murat Tuzcu, Kathy Wolski, et al.
Journal of the American College of Cardiology|June 29, 2010
Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) studyCarl J Pepine, R David Anderson, Barry L Sharaf, et al.
Journal of the American Heart Association|March 4, 2014
Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE StudySteven M Smith, Tianyao Huo, B Delia Johnson, et al.
Journal of Women'S Health (2002)|November 8, 2006
Lifestyle intervention and coronary heart disease risk factor changes over 18 months in postmenopausal women: the Women On the Move through Activity and Nutrition (WOMAN study) clinical trialLewis H Kuller, Laura S Kinzel, Kelley K Pettee, et al.
Journal of the American College of Cardiology|November 21, 2007
Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE studyViola Vaccarino, B Delia Johnson, David S Sheps, et al.
American Heart Journal|March 3, 2015
Mild renal dysfunction and long-term adverse outcomes in women with chest pain: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)Rajesh Mohandas, Mark Segal, Titte R Srinivas, et al.
Pageof 9